Effects of Supplementation on Performance in Football Players (FOOTBALL-TCP)
Effects of Combined Taurine, Caffeine, and Phosphatidylserine Supplementation on Physical and Cognitive Performance in Professional Male Football Players
This study investigated the effects of short-term supplementation with taurine, caffeine, and phosphatidylserine on physical and cognitive performance in professional male football players. Eighty-one players were randomly assigned to one of three groups: placebo, taurine plus caffeine, or taurine plus caffeine combined with phosphatidylserine. Supplementation was administered for 10 days, with a final dose taken 60 minutes before a standardized 105-minute football training session.
Primary and secondary outcomes included sprint performance, reaction time, GPS-derived locomotor variables, and technical and tactical performance indicators. The aim of the study was to evaluate whether combined multi-ingredient supplementation could improve performance and attenuate fatigue-related declines under match-like conditions.
Panoramica dello studio
Stato
Condizioni
Descrizione dettagliata
This randomized, placebo-controlled, single-blind study evaluated the effects of combined supplementation with taurine, caffeine, and phosphatidylserine on physical and cognitive performance in professional male football players.
Eighty-one participants aged 19-32 years were randomly assigned to one of three groups: placebo (lactose), taurine plus caffeine (1500 mg taurine + 200 mg caffeine), or taurine plus caffeine plus phosphatidylserine (1500 mg taurine + 150 mg caffeine + 300 mg phosphatidylserine daily for 10 days). All participants completed a 10-day supplementation period, followed by a standardized 105-minute football training session.
Outcome measures included sprint performance (30 m sprint time), reaction time (visual and auditory), GPS-derived variables (total distance, sprint activity, speed, accelerations, and decelerations), and technical and tactical performance indicators assessed by coaching staff and video analysis.
The study was conducted under controlled environmental conditions and in accordance with standardized training procedures. Data were analyzed using analysis of variance (ANOVA) with post hoc testing. The aim was to determine whether multi-ingredient supplementation could enhance performance and reduce fatigue-related declines in a football-specific setting.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Łódżkie
-
Lodz, Łódżkie, Polonia, 94-020
- ŁKS Łódź
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Adulto
Accetta volontari sani
Descrizione
Inclusion Criteria:
- Male professional football (soccer) players
- Age 19-32 years
- Currently participating in regular team training (4-5 sessions per week)
- Medically cleared for participation in high-intensity physical activity
- Provided written informed consent
Exclusion Criteria:
- Current injury or musculoskeletal condition affecting performance
- Chronic disease or medical condition
- Use of medications that may affect physical or cognitive performance
- Regular use of dietary supplements or caffeine prior to the study period
- Smoking or alcohol consumption
- Failure to comply with study procedures
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Scienza basilare
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Doppio
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Comparatore placebo: Placebo
Participants received a placebo (lactose) daily for 10 days.
|
Placebo (lactose) administered daily for 10 days
|
|
Sperimentale: Taurine + Caffeine
Participants received taurine (1500 mg) and caffeine (200 mg) daily for 10 days.
|
Taurine 1500 mg and caffeine 200 mg administered daily for 10 days
|
|
Sperimentale: Taurine + Caffeine + PS
Participants received taurine (1500 mg), caffeine (150 mg), and phosphatidylserine (300 mg) daily for 10 days.
|
Taurine 1500 mg, caffeine 150 mg, and phosphatidylserine 300 mg administered daily for 10 days
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
30 m sprint time (seconds)
Lasso di tempo: Day 10 (final training session following supplementation)
|
Time to complete a 30 meter sprint under standardized conditions, expressed in seconds; calculated as the mean of valid trials.
|
Day 10 (final training session following supplementation)
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Reaction time (visual and auditory)
Lasso di tempo: Day 10 (post-supplementation)
|
Visual and auditory reaction time measured using standardized computerized reaction time tests (e.g., validated software-based assessment tools), expressed as mean response time in seconds across valid trials.
|
Day 10 (post-supplementation)
|
|
Total distance (meters)
Lasso di tempo: Day 10 (during standardized training session)
|
Total distance covered during the standardized training session, measured using GPS tracking devices (e.g., 10 Hz GPS units), expressed in meters.
|
Day 10 (during standardized training session)
|
|
Running speed (m/s)
Lasso di tempo: Day 10 (during standardized training session)
|
Mean running speed during the standardized training session, measured using GPS tracking devices (e.g., 10 Hz GPS units), expressed in meters per second.
|
Day 10 (during standardized training session)
|
|
Sprint count (number)
Lasso di tempo: Day 10 (during standardized training session)
|
Total number of sprint efforts recorded during the standardized training session using GPS tracking devices.
|
Day 10 (during standardized training session)
|
|
High-speed running distance (meters)
Lasso di tempo: Day 10 (during standardized training session)
|
Distance covered at high-speed running thresholds during the standardized training session, measured using GPS tracking and expressed in meters.
|
Day 10 (during standardized training session)
|
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Sprint time decline (%)
Lasso di tempo: Day 10 (during final training session; comparison between first and second halves)
|
Percentage decline in 30 m sprint time between the first and second halves of the standardized training session, measured using electronic timing gates and expressed as percentage change.
|
Day 10 (during final training session; comparison between first and second halves)
|
|
Running speed decline (%)
Lasso di tempo: Day 10 (during final training session; comparison between first and second halves)
|
Percentage decline in running speed between the first and second halves of the standardized training session, measured using GPS tracking devices and expressed as percentage change.
|
Day 10 (during final training session; comparison between first and second halves)
|
|
Passing accuracy (%)
Lasso di tempo: Day 10 (during standardized training session)
|
Percentage of successful passes during the standardized training session, assessed using video-based performance analysis and expressed as a percentage.
|
Day 10 (during standardized training session)
|
|
Dribbling success (%)
Lasso di tempo: Day 10 (during standardized training session)
|
Percentage of successful dribbling attempts during the standardized training session, assessed using video-based performance analysis and expressed as a percentage.
|
Day 10 (during standardized training session)
|
|
Ball recoveries (number)
Lasso di tempo: Day 10 (during standardized training session)
|
Total number of ball recoveries performed during the standardized training session, assessed using video-based performance analysis and expressed as a count.
|
Day 10 (during standardized training session)
|
|
Tactical performance score (units)
Lasso di tempo: Day 10 (during standardized training session)
|
Coach-rated tactical performance during the standardized training session, including positioning, decision-making, and support play, assessed using a standardized rating scale and expressed in standardized score units.
|
Day 10 (during standardized training session)
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Krzysztof Maciej MIZERA, PhD, 1. Vizja University in Warsaw, Faculty of Medical Sciences and Health Sciences, 01-143 Warsaw, Poland
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
- Composti di zolfo
- Prodotti chimici organici
- Composti eterociclici
- Composti eterociclici, 2 anelli
- Composti eterociclici, anello fuso
- Lipidi
- Idrocarburi, aciclici
- Idrocarburi
- Alcaloidi
- Purinoni
- Purine
- Alcani
- Acidi alcanesolfonici
- Acidi solfonici
- Acidi zolfo
- Lipidi a membrana
- Xantine
- Glicerofosfolipidi
- Acidi fosfatidici
- Glicerofosfati
- Fosfolipidi
- Caffeina
- Taurina
- Fosfatidilserine
Altri numeri di identificazione dello studio
- MIZERA-2025-FOOTBALL-RCT
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .